Cerevel Therapeutics Holdings Inc (CERE)
41.51
-0.12
(-0.29%)
USD |
NASDAQ |
May 24, 13:30
Cerevel Therapeutics Holdings Cash and Short Term Investments (Quarterly): 846.29M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 846.29M |
| December 31, 2023 | 990.96M |
| September 30, 2023 | 676.88M |
| June 30, 2023 | 736.43M |
| March 31, 2023 | 826.99M |
| December 31, 2022 | 892.03M |
| September 30, 2022 | 989.92M |
| June 30, 2022 | 531.21M |
| Date | Value |
|---|---|
| March 31, 2022 | 542.94M |
| December 31, 2021 | 565.69M |
| September 30, 2021 | 669.68M |
| June 30, 2021 | 327.06M |
| March 31, 2021 | 343.29M |
| December 31, 2020 | 383.62M |
| September 30, 2020 | 0.6094M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.6094M
Minimum
Sep 2020
990.96M
Maximum
Dec 2023
621.57M
Average
669.68M
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| AbbVie Inc | 18.07B |
| Bristol-Myers Squibb Co | 9.67B |
| Madrigal Pharmaceuticals Inc | 1.059B |
| Viking Therapeutics Inc | 962.98M |
| Karuna Therapeutics Inc (DELISTED) | 1.263B |